MvPI Compliance Alert 2026: New Adverse Event Reporting Rules
IPC's January 2026 directive tightens adverse event reporting for medical device MAHs via ADRMS. Here's what license holders must do…
Read MoreRegulatory updates, compliance insights, and industry analysis from the ACPL team.
IPC's January 2026 directive tightens adverse event reporting for medical device MAHs via ADRMS. Here's what license holders must do…
Read MorePHARMACOVIGILANCE • REGULATORY CONSULTING • INDIA Pharmacovigilance Consulting Services in India Professional pharmacovigilance and drug-safety consulting support for pharmaceutical companies,…
Read MoreCDSCO Consultant in Delhi | Drug & Medical Device Registration CDSCO REGULATORY CONSULTING • DELHI NCR CDSCO Consultant in Delhi…
Read MoreCDSCO REGULATORY CONSULTING • INDIA CDSCO Consultant in India Complete support for CDSCO registration, drug import licensing, medical device registration,…
Read More
Entering the Indian Pharmaceutical Market: A Practical Guide for European Pharma Companies India’s pharmaceutical market is massive, but it’s not…
Read MoreMeat, poultry and seafood businesses face tighter FSSAI scrutiny in 2026 — new turnover thresholds, a sausage-standard deadline, and zero…
Read More
CPCB just made life easier for anyone managing EPR accounts with their new “Lost Credentials” feature. If you’re stuck because…
Read More
CDSCO Issues Guidance for Importing and Marketing Globally Unapproved New Drugs After Phase III Trials On August 10, 2026, the…
Read More
Why Your BIS Certification Application Gets Rejected—and What You Can Do About It Getting BIS Certification isn’t just another box…
Read MoreCDSCO has floated a tender to build a next-gen Digital Drugs Regulatory System while SUGAM adds new modules. Here's what…
Read More